| 000 | 01355 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513080610.0 | ||
| 264 | 0 | _c19930407 | |
| 008 | 199304s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchlager, J J | |
| 245 | 0 | 0 |
_aIncreased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells. _h[electronic resource] |
| 260 |
_bCancer research _cMar 1993 |
||
| 300 |
_a1338-42 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3T3 Cells _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAziridines _xpharmacology |
| 650 | 0 | 4 |
_aBenzoquinones _xpharmacology |
| 650 | 0 | 4 | _aBlood Physiological Phenomena |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aCell Transformation, Neoplastic |
| 650 | 0 | 4 |
_aGrowth Substances _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 700 | 1 | _aHoerl, B J | |
| 700 | 1 | _aRiebow, J | |
| 700 | 1 | _aScott, D P | |
| 700 | 1 | _aGasdaska, P | |
| 700 | 1 | _aScott, R E | |
| 700 | 1 | _aPowis, G | |
| 773 | 0 |
_tCancer research _gvol. 53 _gno. 6 _gp. 1338-42 |
|
| 999 |
_c8443086 _d8443086 |
||